Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-20-000193 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
613.25% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 22th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.25% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
37.55% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
52.34% · CORE · NOT_ENOUGH_HISTORY
Gross margin 0th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
77.75% · CORE · VALID
Operating margin 0th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
-29.93% · CORE · VALID
R&D intensity 100th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
25.09% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
40.11% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 199.79%
Current 613.25%
Delta 413.46% Capex Intensity Decreased
Previous 9.99%
Current 6.25%
Delta -3.74% Cash Generation Increased
Previous 18.39%
Current 37.55%
Delta 19.15% Growth Increased
Previous 42.41%
Current 52.34%
Delta 9.93% Margin Decreased
Previous 77.80%
Current 77.75%
Delta -0.05% Profitability Decreased
Previous -26.42%
Current -29.93%
Delta -3.50% R And D Intensity Increased
Previous 22.70%
Current 25.09%
Delta 2.39% Sbc Intensity Increased
Previous 28.15%
Current 40.11%
Delta 11.96% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.